Molecular targeted therapy of non-small cell lung cancer in China: the first 10 years
Shi, Y.; Sun, Y.
Zhonghua Yi Xue Za Zhi 95(8): 564-569
2015
ISSN/ISBN: 0376-2491 PMID: 25917029 Document Number: 682994
Document emailed within 1 workday
Related Documents
Herbst, R.S. 2002: Targeted therapy in non-small-cell lung cancer Oncology 16(9 Suppl 9: 19-24Wu, G.; Qian, G. 2014: Further intensifying researches on targeted therapy for non-small cell lung cancer Zhonghua Yi Xue Za Zhi 94(30): 2321-2323
Shi, Y.; Sun, Y. 2014: The development trend of targeted therapy in non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 36(7): 481-484
Muhammet Hacioglu, B.; Kostek, O.; Erdogan, B.; Uzunoglu, S.; Cicin, I. 2017: Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 586-591
Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Moro-Sibilot, D.; Coudurier, M. 2009: Targeted therapies in second line treatment of metastatic non-small cell lung cancer La Revue du Praticien 59(7): 955-956
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Okamoto, I. 2008: Molecular targeting therapy for treatment of non-small-cell lung carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1303-1309
Erlich, R.; Levitt, M.L. 1995: Update in the treatment and molecular biology of non-small cell lung cancer Comprehensive Therapy 21(8): 445-457
Mano, H. 2009: New molecular targeted EML4-ALK for lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(8): 1268-1270
Kumar, A.; Ramanathan, K. 2015: Analyzing resistance pattern of non-small cell lung cancer to crizotinib using molecular dynamic approaches Indian Journal of Biochemistry and Biophysics 52(1): 23-28
Xu, C-hua.; Yu, L-ke.; Zhang, Y.; Xie, H-yan.; Hao, K-ke.; Hu, W.; Xia, N.; Zhan, P. 2012: Analysis of prognostic factors of non-small cell lung cancer in patients under 40 years of age Zhonghua zhong liu za zhi 34(9): 703-705
Hansen, O.; Paarup, H.; Sørensen, P.; Hansen, K.Holmskov.; Werenberg, K.Aage. 2005: Curative radiotherapy of local advanced non-small-cell lung cancer. Eight years of experience from Odense Ugeskrift for laeger 167(37): 3497-3502
Bunn, P.A. 1996: Current therapy of small cell lung cancer Seminars in Oncology 23(6 Suppl 16): 1-4
Seydel, H.G.; Creech, R.H.; Mietlowski, W.; Perez, C. 1978: Radiation therapy in small cell lung cancer Seminars in Oncology 5(3): 288-298
Matsumara, A.; Mori, T. 2001: Induction therapy for non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(12): 1826-1832
Postmus, P.E.; Smit, E.F. 1998: Small-cell lung cancer: is there a standard therapy? Oncology 12(1 Suppl 2: 25-30
Luikart, S.D.; Propert, K.J.; Modeas, C.R.; Green, M.R.; Perry, M.C. 1987: High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(5): 533-534
Ying Geng, Z.; Chang Jiao, S.; Cui Liu, S.; Li, Y.; Feng Liu, Z.; Qing Zhang, G.; Jie Wang, L.; Qu, F. 2013: Third-line therapy in advanced non-small cell lung cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 18(4): 899-907